Xcell Therapeutics Inc. (KOSDAQ:373110)
South Korea
· Delayed Price · Currency is KRW 3,170.00
-45.00 (-1.40%)
Jun 27, 2025, 3:30 PM KST
Xcell Therapeutics Market Cap
Xcell Therapeutics has a market cap or net worth of 35.00 billion as of June 27, 2025.
Market Cap
35.00B
Enterprise Value
34.84B
Revenue
1.74B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,170.00
Market Cap Chart
Since July 15, 2024, Xcell Therapeutics's market cap has decreased from 90.22B to 35.00B, a decrease of -61.20%. That is a compound annual growth rate of -64.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 35.00B | -21.14% |
| Dec 30, 2024 | 44.38B | -50.80% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 70.89T |
| Celltrion | 35.32T |
| ALTEOGEN | 20.33T |
| Yuhan | 7,706.69B |
| SK Biopharmaceuticals | 7,150.00B |
| HLB Co., Ltd. | 6,270.01B |
| PharmaResearch | 5,044.17B |
| Peptron | 4,775.96B |